Safety and efficacy of gamma‐secretase inhibitor nirogacestat (PF‐03084014) in desmoid tumor: Report of four pediatric/young adult cases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of gamma‐secretase inhibitor nirogacestat (PF‐03084014) in desmoid tumor: Report of four pediatric/young adult cases

Published:2020-08-06 Issue:10 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Takahashi Takuto¹^ORCID,Prensner John R.²,Robson Caroline D.³,Janeway Katherine A.²^ORCID,Weigel Brenda J.¹

Affiliation:

1. Division of Hematology/Oncology Department of Pediatrics University of Minnesota Minneapolis Minnesota

2. Boston Children's/Dana‐Farber Cancer and Blood Disorders Center Dana‐Farber Cancer Institute Boston Massachusetts

3. Department of Radiology Boston Children's Hospital Boston Massachusetts

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28636

Reference17 articles.

1. ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes

2. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)

3. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients

4. A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral γ-Secretase Inhibitor PF-03084014

5. Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA approved fluorine-containing drugs in 2023;Chinese Chemical Letters;2024-11

2. Gamma-Secretase Inhibitors Downregulate the Profibrotic NOTCH Signaling Pathway in Recessive Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2024-07

3. The Notch signaling pathway in desmoid tumor: Recent advances and the therapeutic prospects;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01

4. Efficacy and safety of compassionate use for rare diseases: a scoping review from 1991 to 2022;Orphanet Journal of Rare Diseases;2023-11-28

5. Update on Familial Adenomatous Polyposis-Associated Desmoid Tumors;Clinics in Colon and Rectal Surgery;2023-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3